Welcome
Support Centre
29 August 2008 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
UKCTG
mental health register
archived registers
all registers
tips on searching
 
Registration
submit trials
 
Information
about mRCT
mRCT FAQs
data items
memorandum
contributors

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
An investigation of the functional significance of marginal riboflavin status in young women
Source of recordUK Clinical Trials Gateway
ISRCTNISRCTN35811298
Date ISRCTN assigned02/08/2007
Local reference number(s)University Research Ref No.: 109242
Public titleAn investigation of the functional significance of marginal riboflavin status in young women
Scientific title
AcronymRiboFem
Disease/condition/study domainImpaired handling of iron
Study hypothesisNational Diet and Nutrition Surveys show that in certain groups of the population there is a high proportion of people with biochemical evidence of poor riboflavin status. The functional significance of this is not clear.

We will examine the hypothesis that marginal riboflavin status is associated with impaired handling of iron. The results will help to clarify the functional significance of marginal riboflavin status and inform debate regarding dietary recommendations for this nutrient.
Design/methodologyRandomised, double-blind, placebo controlled interventional trial.
Research ethics reviewApproval received from the Sheffield University Research Ethics Committee on the 15th March 2006 (ref: SMBRER15).
Countries of trialUnited Kingdom
Participants - inclusion criteria1. Women aged 19 to 25 years
2. Low milk consumption (less than 200 ml a day)
3. Healthy
4. Marginal riboflavin deficiency as measured by an Erythrocyte Glutathione Reductase Activation Coefficient of greater than 1.4
Participants - exclusion criteria1. Use of multivitamin or iron supplements (within last three months)
2. Diagnosed gastrointestinal disorders: coeliac disease, ulcerative colitis, Crohns disease or inflammatory bowel disease
3. Blood donors
4. Haemochromatosis
5. Pregnancy
Patient information materialParticipant information sheet can be located at: http://www.riboflavin.group.shef.ac.uk/riboflavininfosheet.pdf
Anticipated start date01/04/2006
Anticipated end date30/12/2007
Status of trialCompleted
Target number of participants120
InterventionsMain study:
Three intervention groups:
1. 2 mg riboflavin for eight weeks
2. 4 mg riboflavin for eight weeks
3. Placebo for eight weeks

Bioavailability study:
32 volunteers from the main study randomly assigned to participate in additional bioavailability study involving consumption of special meals two weeks before and immediately after the main study. These meals will contain a stable isotope of iron (Fe58).
Primary outcome measure(s)Main study, measured at baseline and after eight weeks intervention:
1. Measures of iron and haematological status:
1.1. Ferritin
1.2. Haemoglobin
1.3. Mean Corpuscular Volume (MCV)
1.4. Mean Corpuscular Haemoglobin Concentration (MCHC)
1.5. Red Blood Cells (RBC)
1.6. Haematocrit
1.7. Zinc Protoporphyrin (ZPP)
1.8. Soluble Transferrin Receptor (sTFR)

Bioavailability study, additional outcomes measured at baseline and two weeks after dose of isotopic iron (repeated on two separate occasions before and after main study):
Incorporation of Fe58 into erythrocytes.
Secondary outcome measure(s)Lowering of plasma homocysteine.
Trial websitehttp://www.riboflavin.group.shef.ac.uk
Sources of fundingFood Standards Agency (UK) (ref: N05061)
Sponsor nameUniversity of Sheffield (UK)
Sponsor detailsResearch Office
New Spring Road
231 Glossop Road
Sheffield
United Kingdom
S10 2GW
Sponsor telephone+44 (0)114 222 1441
Sponsor emailresearch.office@sheffield.ac.uk
Sponsor websitehttp://www.shef.ac.uk/
Contact nameProf Hilary Powers
Contact detailsHuman Nutrition Unit
School of Medicine & Biomedical Sciences
The University of Sheffield
Beech Hill Road
Sheffield
United Kingdom
S10 2RX
Contact telephone+44 (0)114 226 1346
Contact emailh.j.powers@sheffield.ac.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN35811298
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
terms & conditions | privacy statement | © Current Controlled Trials Ltd


BioMed Central